Utah biotech company to buy Austin’s Rules-Based Medicine for $80 million
Thursday, April 28th, 2011
A Utah-based biotechnology party has agreed to buy Austin’s Rules-Based Medicament Inc. for $80 jillion in cash, the companies aforementioned Wednesday.
Countless Genetics Inc. of Saltiness Lake Metropolis aforementioned the hatful expands its search portfolio to admit biomarkers for new diseases including psychiatrical disorders, infections diseases and incendiary diseases.


By Alison Fensterstock, The Times-Picayune NOLA.com
Washboard Chaz at Chaz Fest 2007.